A 2022 recall stopped the launch of Roche's eye implant, Susvimo, due to manufacturing concerns. This is good news for patients with wet age-related macular degeneration (AMD) as Susvimo is a refillable eye implant that only requires two refills per year offering an alternative to standard-of-care eye injections to treat the disease.
Click here to read the entire article.